Detalhe da pesquisa
1.
Short-term outcomes of a COVID-adapted triage pathway for colorectal cancer detection.
Colorectal Dis
; 23(7): 1639-1648, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682302
2.
Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study.
Liver Int
; 40(9): 2252-2262, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32638496
3.
γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes Study.
Diabetologia
; 58(7): 1484-93, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820150
4.
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.
J Hepatol
; 60(2): 384-91, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24512822
5.
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study.
Liver Int
; 34(8): 1267-77, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24237940
6.
Addition of hyaluronic acid to the FIB-4 liver fibrosis score improves prediction of incident cirrhosis and hepatocellular carcinoma in type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
Obes Sci Pract
; 7(5): 497-508, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34631129
7.
Renal cell carcinoma needle biopsy: sowing the seed for later complications?
BMJ Case Rep
; 20142014 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788630
8.
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
Diabetes Care
; 34(5): 1139-44, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21478462